Health
Moderna launches COVID-19 vaccine booster study to address new variants – PMLiVE
First participants receive company’s modified vaccine candidates
Moderna has begun giving booster doses of its COVID-19 vaccine to trial participants as part of an amendment to a phase 2 clinical study.
The phase 2 trial amendment has enrolled 60 participants who have already received Moderna’s original mRNA-1273 vaccine. They will receive a single booster dose of a modified candidate addressing the B.1.351 variant or a multivalent booster candidate.
The variant-specific booster candidate – mRNA-1273.351 – encodes for the spike protein of the SARS-CoV-2 variant…
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News12 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News22 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General18 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz